Product Name:Mitoquinone
Other Name:Mito-Q;MitoQ;47BYS17IY0;
UNII-47BYS17IY0;
Mitoquinone cation;
Mitoquinone ion;
triphenylphosphanium;
MitoQ; MitoQ10;
10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl-;
CAS No:444890-41-9
Specifications: 98.0%
Colour: Brown powder with characteristic odor and taste
GMO Status:GMO Free
Packing: in 25kgs fiber drums
Storage:Keep container unopened in cool, dry place,Keep away from strong light
Shelf Life:24 months from date of production
Mitoquinone (MitoQ) Product Description
CAS#: 444890-41-9 | Purity: ≥99% | Storage: -20°C
Product Overview
Mitoquinone (MitoQ) is a mitochondria-targeted antioxidant derived from ubiquinone (CoQ10), covalently linked to a lipophilic triphenylphosphonium (TPP) cation. This unique structure enables MitoQ to accumulate hundreds of times within mitochondria, specifically neutralizing reactive oxygen species (ROS) and protecting against oxidative damage .
Key Features
- Mechanism of Action
- Targeted Delivery: The TPP cation drives accumulation in mitochondria, enhancing protection against mitochondrial ROS overproduction .
- Redox Activity: MitoQ’s ubiquinone moiety is reduced to ubiquinol, actively scavenging free radicals and restoring mitochondrial membrane potential .
- Proven Benefits in Research
- Liver Protection: Reduces hepatic oxidative stress, inflammation, and fibrosis in cirrhotic models .
- Neuroprotection: Improves mitochondrial function in Alzheimer’s and Parkinson’s disease models, attenuates neuronal death, and enhances motor performance .
- Cardiometabolic Effects: Alleviates lipid-induced insulin resistance and improves glucose homeostasis under oxidative stress .
- In Vivo & In Vitro Efficacy
- Dosage Flexibility: Effective in animal studies at 5–10 mg/kg (intraperitoneal) and 25–100 mg/kg (oral) .
- Human Pharmacokinetics: Orally absorbed with detectable muscle concentrations (Cmax: ~3.84 µmol/g) at safe doses (160 mg) .
Product Specifications
- Form: Solid/Powder
- Purity: ≥99% (HPLC/NMR verified)
- Storage: -20°C (stable for 3 years in powder form; DMSO solutions: -80°C for ≤3 months) .
- Packaging: 1 mg, 5 mg, 10 mg (custom orders available)
Applications
- Research Areas:
- Neurodegenerative Diseases: Mitigates mitochondrial dysfunction in Parkinson’s and Alzheimer’s models .
- Liver Fibrosis: Reduces hepatic inflammation and oxidative damage .
- Metabolic Disorders: Improves insulin sensitivity under lipid stress .
- Cardiovascular Protection: Attenuates ischemia-reperfusion injury and endothelial dysfunction .
- Experimental Models:
- Cell lines (e.g., SH-SY5Y, HK-2) and animal models (mice, rats) .
Safety & Compliance
- For Research Use Only: Not intended for human or clinical use .
- Handling: Use personal protective equipment (gloves, lab coat); avoid inhalation or direct contact .
- Solubility: Recommended in DMSO (stock solutions stable at -20°C) .
Why Choose Our MitoQ?
- High Purity: Rigorous quality control ensures ≥99% purity via TLC and NMR .
- Global Supply: Available from multiple suppliers (e.g., XAQYBIO, GLPBIO, MedChemExpress) with fast shipping .
- Scientific Backing: Cited in Nature, Cell, and Journal of Nanobiotechnology for robust experimental validation .
Keywords
Mitochondria-targeted antioxidant, MitoQ, CAS 444890-41-9, oxidative stress, neuroprotection, liver fibrosis, insulin resistance, ROS scavenger, CoQ10 derivative.